(60 days)
No
The document mentions standard image reconstruction methods like FBP and ML-EM/OSEM, which are not inherently AI/ML. There is no mention of AI, ML, or related terms like deep learning or neural networks.
Yes
The device is described as an "Attenuation Correction Device (ACD)" for gamma cameras, and its intended use is to enhance emission images by correcting for attenuation and scatter effects, with the resulting information being "useful in the diagnosis determination" when interpreted by a physician. This function clearly falls under the definition of a therapeutic device (which includes aiding in diagnosis).
Yes
The device "provides an enhancement to the emission images acquired SPECTRADigital™ Series V250DSP by correcting for attenuation and scatter effects in the patient. When resulting images are interpreted by a trained physician, the information provided can be useful in the diagnosis determination." This indicates its role in aiding diagnostic processes.
No
The device description explicitly states that the device is a "combination of hardware and software" and details the hardware components, including a line source holder, shutter, and collimation.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that this device is an "Attenuation Correction Device (ACD)" used with a gamma camera for SPECT imaging. It works by acquiring transmission data using an external radioactive source and applying corrections to emission images acquired from the patient.
- No Sample Analysis: The device does not analyze any biological samples taken from the patient. Its function is to improve the quality of in-vivo (within the living body) imaging data.
Therefore, while it is a medical device used in diagnosis, it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
Intended uses of Convergences™ NUA® for Hitachi SPECTRADigital™ V250DSP Gamma Cameras is identical to the ADAC Vantage ExSPECT 2.1 cleared under K971878 in system function and operational software. These include:
- Acquisition of patient specific anatomic density via transmission imaging to determine attenuation coefficients applicable to emission slice data.
- Reconstruction of transmission and emission SPECT data via FBP and/or ML-EM/OSEM reconstruction methods
- Analysis and generation of attenuation maps and coefficients to apply to emission SPECT slice/volume sets.
The acquisition of SPECT is as cleared under SPECTRADigital™Series V250DSP system K954129, with addition of transmission acquisition protocols to produce images which depict anatomical density of a patient. The device is intended to provide an enhancement to the emission images acquired SPECTRADigital™ Series V250DSP by correcting for attenuation and scatter effects in the patient. When resulting images are interpreted by a trained physician, the information provided can be useful in the diagnosis determination.
Hitachi capabilities with Convergence SM NUA SM for Imaging SPECTRADigital™ V250DSP Gamma Cameras option include:
- All SPECT procedures in common practice including matrix based spatial framed, temporal/spatial list mode and angular projection mode static, gated and multi-orbit sampling
- High and normal count-rate dynamic and non-temporal SPECT
- In conjunction with additional options for Coincidence based imaging, the detector performance and NUA®ª acquisition and processing characteristics are available for non-uniform attenuation SPECT, attenuation correction in CID and CID based ECT imaging (these options are covered under separate and exclusive PMAs)
- Multiple window sampled imaging, including scatter correction via single, dual or plural window processing.
Product codes (comma separated list FDA assigned to the subject device)
90KPS
Device Description
Convergence 3M NUA 3M for Hitachi SPECTRADigital™ V250DSP Gamma Cameras is an optional Attenuation Correction Device (ACD) that provides capability to map anatomical information using external radioactive line source transmission, analyze densities and assign patient specific attenuation coefficients to minimize distortion caused by false information in the emission computer tomographic images due to overlying tissue and undesired scattered photons. The device is a combination of hardware and software to provide transmission, collimation, acquisition and analysis/correction of ECT data.
The Hardware which consists of a single, non-moving line source holder equipped with shutter, special line source slat collimation to minimize patient exposure and axial scatter and fan beam collimation. The standard source is Gadolinium 153 (240.4d T1/2, 97.4~103.2 keV, while the system has been confirmed with Technetium 99m ( 6hr T1/2, 140.5 keV) and Cerium-139 (137.6d T1/2, 165.8 keV).
The software consists of camera based transmission acquisition control and workstation based OSEM iterative and/or FBP (Filtered Back-Projection) reconstruction, coefficient determination and correction to ECT slice data. The system uses the same camera mechanical platform, table, collimators, electrical system and acquisition/system operating software cleared under K954129, with the addition of acquisition/processing sequences to correct for scatter and effects of attenuation. The acquisition of transmission and emission data is performed via fast sequential orbit acquisition to minimize effects of cross-spill and cross falk. A detailed description can be found in Attachment 1. Detailed device specifications can be found in Attachment 4.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
SPECT
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
In the code implementation, simulation and phantom processed studies, acquisition, analysis and correction results have been thoroughly tested and verified to operate properly and as intended. The results of transmission reconstruction and attenuation coefficient determination has proven effective. Clinical tests have documented effective application and expected results consistent with predicate devices currently in commercial distribution.
Medical believes the ConvergencesM NUA sM Hitachi for Hitachi SPECTRADigital™ V250DSP Gamma Cameras, an Attenuation Correction Device (ACD), to be substantially equivalent to Gamma Camera Systems currently in commercial distribution in the U.S. We have tested the Convergence SM NUA SM for Hitachi SPECTRADigital™ V250DSP Gamma Cameras with the Data Spectrum Anthromophic Phantom, Data Spectrum Delux 5000 SPECT Phantom, Data Spectrum Cardiac Phantom and NEMA Scatter Phantom to establish the basis for proper operation.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
JUN 18 1999
Attachment 1 Summary of Safety and Effectiveness
*Attachments labeled "CONFIDENTIAL" as follows: Hitachi Medical Corporation regards the information defined as part of this Attachment to be a trade secret and confidential in nature.
1
વા 318
1.0 Submitter Information
Hitachi Medical Corporation of America Nuclear Medicine Product Division 9177 Dutton Drive. Twinsburg, Ohio ESTABLISHMENT REGISTRATION NUMBER: 1530450 PH: 330-405-3330 FX: 330-405-3222
Contact Gary W. Enos
Date April 16, 1999
2.0 DEVICE NAME: Convergence SM NUA SM
Classification Panel: Radiology Classification Name: System, Tomographic, Nuclear Classification Number: 892.1200 90KPS Trade/Proprietary Name: Convergence sm NUA SM for Hitachi SPECTRADigital™ V250DSP Gamma Cameras
Predicate Device: ADAC Vantage ExSpect 2.1 system cleared under K971878
3.0 Device Description
Function
Convergence 3M NUA 3M for Hitachi SPECTRADigital™ V250DSP Gamma Cameras is an optional Attenuation Correction Device (ACD) that provides capability to map anatomical information using external radioactive line source transmission, analyze densities and assign patient specific attenuation coefficients to minimize distortion caused by false information in the emission computer tomographic images due to overlying tissue and undesired scattered photons. The device is a combination of hardware and software to provide transmission, collimation, acquisition and analysis/correction of ECT data.
The Hardware which consists of a single, non-moving line source holder equipped with shutter, special line source slat collimation to minimize patient exposure and axial scatter and fan beam collimation. The standard source is Gadolinium 153 (240.4d T1/2, 97.4~103.2 keV, while the system has been confirmed with Technetium 99m ( 6hr T1/2, 140.5 keV) and Cerium-139 (137.6d T1/2, 165.8 keV).
The software consists of camera based transmission acquisition control and workstation based OSEM iterative and/or FBP (Filtered Back-Projection) reconstruction, coefficient determination and correction to ECT slice data. The system uses the same camera mechanical platform, table, collimators, electrical system and acquisition/system operating software cleared under K954129, with the addition of acquisition/processing sequences to correct for scatter and effects of
2
attenuation. The acquisition of transmission and emission data is performed via fast sequential orbit acquisition to minimize effects of cross-spill and cross falk. A detailed description can be found in Attachment 1. Detailed device specifications can be found in Attachment 4.
Scientific Concepts:
Over lying anatomical structures of varied densities and in-patient scatter are known to cause distortion to the determination of radionuclide distribution(s) in-vivo. Spatial and contrast representation of radionuclide distribution is degraded by photon attenuation and scatter. Fixed geometrical and linear attenuation corrections (ie. Chang and Sorenson methods) are simple estimations. In addition, attempts to manage the effects of scatter via pre and/or post scatter sampled window subtraction techniques serve to perturb Poisson noise statistics and reconstruction weighting values contributive to tomographic results.
A more accurate method of attenuation and scatter correction has been the basis for patient specific transmission imaging and spectral scatter window sampling techniques. Fan beam acquisition and reconstruction is documented to improve geometrical sensitivity and resolution limited only by the intrinsic resolution of the camera system and the solid angle of the focal distance of the collimator. For transmission imaging, the diameter of the line source is an additional consideration to the resolution achievement potential. Utility of longer focal length symmetric fan beam collimation (77cm) positioned offset to the axis of rotation mimics asymmetric fan beam geometry, thereby markedly increasing the viewing volume to reduce potential for truncation.
In combination with Iterative ML-EM and OSEM reconstruction methods (known to accurately incorporate the Poisson nature of photon noise and a number of other relevant physical factors), improved tomographic results in terms of image contrast and quantitative accuracy are well documented via Monte-Carlo, phantom and real patient conditions. The combination of documented and proven Fan Beam acquisition and reconstruction and well collimated line source geometry, improvements in data acquisition density (Signal-to-Noise) and resolution input function provide an accurate basis for transmission and emission volume correlation.
The Convergence® NUA® for Hitachi SPECTRADigital™ V250DSP Gamma Cameras is an Attenuation Correction Device (ACD) incorporates the applied improvements of offset fan beam (1/2 fan) acquisition/reconstruction, single line non-moving source, axial collimation, OSEM iterative reconstruction, scatter window sampled correction and density specific attenuation correction to emission ECT tomographic distributions.
5.0 Device Technological Characteristics:
Technologies associated with Convergence SM NUA sm for Hitachi SPECTRADigital™ V250DSP Gamma Cameras are defined in Attachment 4. Key elements include:
3
- Symmetric Fan Beam Collimation with a 77cm, focal length �
- Utilization of offset fan beam parameters and detector/collimator orientation to � minimize truncation and increase viewing volume (increase the TCT FOV)
- Axial collimated line source of NRC registered and approved sources in the � 1.5~3mm diameter range
- Shutter controlled transmission with absorber plates to manage source strength, � transmission beam characteristics (area and profile)
- � Sequentially acquired Transmission and Emission data to minimize cross contamination
- Scatter window sampling to modulate transmission and emission data as part � of the reconstruction domain.
- OSEM iterative reconstruction of transmission and emission data to maximize � resolution and quantification accuracy.
- � Segmentation of anatomical regions and anatomical densities to correct attenuation effects in emission SPECT.
6.0 Testing and Equivalence
In the code implementation, simulation and phantom processed studies, acquisition, analysis and correction results have been thoroughly tested and verified to operate properly and as intended. The results of transmission reconstruction and attenuation coefficient determination has proven effective. Clinical tests have documented effective application and expected results consistent with predicate devices currently in commercial distribution.
Medical believes the ConvergencesM NUA sM Hitachi for Hitachi SPECTRADigital™ V250DSP Gamma Cameras, an Attenuation Correction Device (ACD), to be substantially equivalent to Gamma Camera Systems currently in commercial distribution in the U.S. We have tested the Convergence SM NUA SM for Hitachi SPECTRADigital™ V250DSP Gamma Cameras with the Data Spectrum Anthromophic Phantom, Data Spectrum Delux 5000 SPECT Phantom, Data Spectrum Cardiac Phantom and NEMA Scatter Phantom to establish the basis for proper operation.
In accordance with NUREG-1556 of the Nuclear Requlatory Commission for emitter source devices, the devices emissions, leakage, patient dose and safe controls are consistent with requirement and those of commercially approved devices.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Rockville MD 20850
Food and Drug Administration 9200 Corporate Boulevard
JUN 18 1999
Gary W. Enos Hitachi Medical Corporation 9177 Dutton Drive Twinsburg, Ohio 44056
Re:
K991318 Convergence NUA for SpectraDigital V250DSP System Dated: April 16, 1999 Received: April 19, 1999 Regulatory class: II 21 CFR 892.1200/Procode: 90 KPS
Dear Mr. Enos:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
Image /page/4/Picture/14 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged around the top half of the circle. Inside the circle is a stylized symbol that resembles three abstract human profiles or faces, stacked on top of each other and connected by flowing lines.
Ke.
5
510(k) Number (if known): K991318
Convergence SM NUA SM for Hitachi SPECTRADigital™ V250DSP Device Name: Gamma Cameras
Indications For Use:
Intended uses of Convergences™ NUA® for Hitachi SPECTRADigital™ V250DSP Gamma Cameras is identical to the ADAC Vantage ExSPECT 2.1 cleared under K971878 in system function and operational software. These include:
- Acquisition of patient specific anatomic density via transmission imaging to � determine attenuation coefficients applicable to emission slice data.
- Reconstruction of transmission and emission SPECT data via FBP and/or � ML-EM/OSEM reconstruction methods
- � Analysis and generation of attenuation maps and coefficients to apply to emission SPECT slice/volume sets.
The acquisition of SPECT is as cleared under SPECTRADigital™Series V250DSP system K954129, with addition of transmission acquisition protocols to produce images which depict anatomical density of a patient. The device is intended to provide an enhancement to the emission images acquired SPECTRADigital™ Series V250DSP by correcting for attenuation and scatter effects in the patient. When resulting images are interpreted by a trained physician, the information provided can be useful in the diagnosis determination.
Hitachi capabilities with with with with and Convergence SM NUA SM for for lmaging SPECTRADigital™ V250DSP Gamma Cameras option include:
- I All SPECT procedures in common practice including matrix based spatial framed, temporal/spatial list mode and angular projection mode static, gated and multi-orbit sampling
- 트 High and normal count-rate dynamic and non-temporal SPECT
- 트 In conjunction with additional options for Coincidence based imaging, the detector performance and NUA®ª acquisition and processing characteristics are available for non-uniform attenuation SPECT, attenuation correction in CID and CID based ECT imaging (these options are covered under separate and exclusive PMAs)
- I Multiple window sampled imaging, including scatter correction via single, dual or plural window processing.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| Prescription Use ✓ OR | Over-The-Counter Use ______ |
| (Per 21 CFR 801.109) | |
| (Division Sign-Off) | (Optional Format 1-2-96) |
| Division of Reproductive, Abdominal, ENT, and Radiological Devices | |
| 510(k) Number | K991318 |